
The Morning Brief
Futures are digesting a torrid Monday session even as a fresh wave of Asian chip data and European earnings resets the macro conversation overnight.
Overnight, the signal out of Asia is semiconductors and software, not stimulus.
Taiwan's chip supply chain keeps printing strong numbers: TSMC (TSM) reported October revenue growth, and ASE Technology (ASX) jumped 8.7% after posting its own monthly revenue gain and signing a new construction contract to expand capacity. Alibaba (BABA) is collaborating with Apple on China-market Apple Intelligence features, another sign Beijing is comfortable letting US AI tie-ups through the regulatory door. On the macro side, a UOB economist weighed in on China's interest rate outlook, a reminder that the PBOC's next move is still the swing factor for regional risk appetite. SoftBank (9984) reported a quarterly loss, while Honda raised its full-year outlook on strong first-half earnings and Suzuki posted half-year results, a mixed read on Japan Inc. heading into year-end.
Europe's morning tape leans constructive.
Vodafone (VOD) raised full-year guidance on strong business performance, and HSBC (HSBC), up 3.6%, announced a fresh share repurchase alongside a notable defensive move: it and other UK banks are blocking AI agents from customer accounts, a live data point in the fraud-versus-automation debate banks are now fighting in public. BT Group postponed its Starlink partnership over Ukraine interference concerns. Porsche SE reported a loss tied to impairments on its Volkswagen stake, and Ireland's largest residential REIT agreed to a EUR 731 million buyout from Barings, a sign private capital is still bidding for yield in European real estate.
The AI infrastructure debate is spilling into the power and autos complex.
Kevin O'Leary called Texas's political shift a "shockeroo" for AI investors, warning that data-center capacity will simply relocate if the state turns hostile, a comment touching Tesla (TSLA), AMD, JPMorgan and SpaceX. Separately, CATL signed a long-term cooperation deal with Seres and is expanding sodium-ion battery-swapping infrastructure, underscoring how aggressively China's battery supply chain is scaling even as Western AI capex debates get political.
Single names to watch:
Humana (HUM) is down 2.4% after a string of sell-side price-target cuts and a new cash tender offer on its debt, a combination that reads as balance-sheet defense rather than confidence. Bayer picked up FDA approval for its stroke-risk drug asundexian, a clean clinical win in an otherwise quiet pharma tape.
On the radar today:
a packed earnings slate includes CoreWeave, eToro, Sea Limited, TransDigm, On Holding, Wix, D-Wave and Bitdeer, with AI-infrastructure and crypto-adjacent names likely to set the tone for risk appetite into the bell.
Bottom line: the rally that pushed the S&P, Nasdaq and small caps all up sharply on Monday now meets an overnight tape full of crosscurrents, strong Asian chip data and European guidance raises on one side, a Humana-led credit wobble and a brewing AI-power political fight on the other.